Have a feature idea you'd love to see implemented?
Let us know!
TVGN Tevogen Bio Holdings Inc.
Price (delayed)
$1.64
Market cap
$287.08M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.13
Enterprise value
$287.72M
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN
Highlights
The company's quick ratio has surged by 100% QoQ
Tevogen Bio Holdings's equity has surged by 93% YoY and by 19% QoQ
The debt has plunged by 97% YoY but it has grown by 47% from the previous quarter
The net income has soared by 92% year-on-year but it has dropped by 65% since the previous quarter
Key stats
What are the main financial stats of TVGN
Market
Valuations
Earnings
Shares outstanding
175.05M
Market cap
$287.08M
Enterprise value
$287.72M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$4.62M
EBITDA
-$4.22M
Free cash flow
-$10.93M
Per share
Balance sheet
Liquidity
EPS
-$0.13
Free cash flow per share
-$0.06
Book value per share
-$0.04
Revenue per share
$0
TBVPS
$0.03
Total assets
$4.29M
Total liabilities
$10.48M
Debt
$2.96M
Equity
-$6.19M
Working capital
-$6.89M
Debt to equity
-0.48
Current ratio
0.34
Quick ratio
0.24
Net debt/EBITDA
-0.15
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-124.1%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TVGN stock price
How has the Tevogen Bio Holdings stock price performed over time
Intraday
15.49%
1 week
10.81%
1 month
-8.89%
1 year
-85.04%
YTD
-85.27%
QTD
345.17%
Financial performance
How have Tevogen Bio Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$53.71M
Net income
-$5.11M
Gross margin
N/A
Net margin
N/A
The net income has soared by 92% year-on-year but it has dropped by 65% since the previous quarter
The operating income has declined by 8% since the previous quarter
Growth
What is Tevogen Bio Holdings's growth rate over time
Valuation
What is Tevogen Bio Holdings stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 81% YoY
Tevogen Bio Holdings's equity has surged by 93% YoY and by 19% QoQ
Efficiency
How efficient is Tevogen Bio Holdings business performance
The return on assets has dropped by 85% since the previous quarter but it has surged by 67% year-on-year
Dividends
What is TVGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TVGN.
Financial health
How did Tevogen Bio Holdings financials performed over time
TVGN's total assets is 59% lower than its total liabilities
The company's quick ratio has surged by 100% QoQ
TVGN's total liabilities has dropped by 89% year-on-year and by 4.2% since the previous quarter
The debt is 148% more than the equity
The debt has plunged by 97% YoY but it has grown by 47% from the previous quarter
Tevogen Bio Holdings's equity has surged by 93% YoY and by 19% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.